Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV-infection in Pregnant Women”

228 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 228 results

Not applicableStudy completedNCT04401670
What this trial is testing

Cervical Cancer Screening in Cameroon

Who this might be right for
Cervical CancerHIV/AIDS
Albert Einstein College of Medicine 873
Not applicableStudy completedNCT04587050
What this trial is testing

Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV

Who this might be right for
HIV InfectionsHuman Papillomavirus InfectionCervical Cancer
Imperial College London 57
Testing effectiveness (Phase 2)Study completedNCT02304770
What this trial is testing

Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia

Who this might be right for
Cervical Persistent High Risk HPV InfectionCervical Intraepithelial Neoplasia
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 73
Not applicableUnknownNCT00892866
What this trial is testing

CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells

Who this might be right for
Atypical Endometrial HyperplasiaHuman Papillomavirus InfectionStage 0 Cervical Cancer AJCC v7
GOG Foundation 877
Large-scale testing (Phase 3)Study completedNCT01047345
What this trial is testing

V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)

Who this might be right for
Cervical CancersVulvar CancersVaginal Cancers+1 more
Merck Sharp & Dohme LLC 924
Not applicableUnknownNCT03931083
What this trial is testing

Screening Test Accuracy of Gynocular™, HR-HPV Testing, VIA for Detection of Cervical Neoplastic Lesions, in Women Living With HIV

Who this might be right for
Uterine Cervical NeoplasmsHIV/AIDS
University of Bern 450
Large-scale testing (Phase 3)Active Not RecruitingNCT04537156
What this trial is testing

Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerCondylomata Acuminata
Xiamen University 9,327
Not applicableLooking for participantsNCT05371353
What this trial is testing

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 600
Not applicableUnknownNCT01897129
What this trial is testing

Human Papillomavirus and Pregnancy

Who this might be right for
HPV-infection in Pregnant Women
Ulla Bonde van Zwol 546
Testing effectiveness (Phase 2)Study completedNCT00091130
What this trial is testing

SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells

Who this might be right for
Atypical Squamous Cells of Undetermined SignificanceCervical CancerHigh-grade Squamous Intraepithelial Lesion+1 more
National Cancer Institute (NCI) 139
Not applicableStudy completedNCT03898167
What this trial is testing

Prospective Evaluation of Self-Testing to Increase Screening

Who this might be right for
Cervical CancerHuman Papillomavirus Infection
Baylor College of Medicine 2,474
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04266275
What this trial is testing

Topical Curcumin for HPV Related Cervical Disease

Who this might be right for
Neoplasm Cervix
Lisa Flowers 200
Not applicableUnknownNCT00728871
What this trial is testing

The Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN) Patients and Their Prognosis

Who this might be right for
Cervical CancerCervical Intraepithelial Neoplasia
National Taiwan University Hospital 600
Not applicableStudy completedNCT01295242
What this trial is testing

Natural History of Human Papillomavirus (HPV) Infections in Mid-Adult Women (WHIM)

Who this might be right for
Papillomavirus Infections
University of Washington 409
Large-scale testing (Phase 3)Study completedNCT00578227
What this trial is testing

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 814
Large-scale testing (Phase 3)Study completedNCT00092495
What this trial is testing

Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 3,055
Not applicableStudy completedNCT02808832
What this trial is testing

An HPV Vaccine Provider Intervention in Safety Net Clinics

Who this might be right for
Human PapillomavirusUterine Cervical Neoplasms
Meharry Medical College 806
Large-scale testing (Phase 3)Study completedNCT00929526
What this trial is testing

Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 752
Large-scale testing (Phase 3)Looking for participantsNCT04422366
What this trial is testing

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+11 more
Shanghai Bovax Biotechnology Co., Ltd. 8,000
Large-scale testing (Phase 3)Study completedNCT00306241
What this trial is testing

Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 300
Load More Results